Status:
UNKNOWN
Clinical Evaluation of an Aerosol Protective Intubation Device on Videolaryngoscopic Intubation Difficulty
Lead Sponsor:
Maisonneuve-Rosemont Hospital
Conditions:
Intubation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The VACCIN box, an anti-aerosol intubation box for potential use on COVID-19 (SARS-CoV-2) positive patients, was designed in order to reduce the transmission risk to healthcare workers. This study wil...
Detailed Description
Novel ways to protect healthcare workers were developed around the world in the setting of the COVID-19 (SARS-CoV-2) pandemic. Shortage of personal protective equipment (PPE) and concern of potential ...
Eligibility Criteria
Inclusion
- Elective surgery requiring general anesthesia with tracheal intubation
- ASA status I, II or III
- Good understanding of English or French
Exclusion
- Known difficult airway
- Anticipated difficult airway (Mallampati ≥ 3, oral opening \< 2.5 cm, thyromental distance \< 6 cm, limited cervical mobility, significant abnormality of the upper respiratory tract, history of major surgery on airway or cervical area)
- COVID-19 positive or unknown status
- Rapid sequence contraindication
- Presence of antibiotic-resistant bacteria requiring a form of additional protective equipment
- Claustrophobia
- Chronic anxiety
- BMI ≥ 35
- Allergy or intolerance to any of the study drugs
- Emergent surgery
- Pregnancy
- Preoperative hemodynamic disturbance
- Patient refusal
Key Trial Info
Start Date :
April 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04865081
Start Date
April 19 2021
End Date
July 1 2021
Last Update
April 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maisonneuve Rosemont Hospital
Montreal, Quebec, Canada, H1T 2M4